Expanded Collaboration with Pfizer Targets Most Common CF Mutation Posted on January 27, 2013 The CF Foundation expands its collaboration with Pfizer Inc., aimed at discovering drugs to treat people with the most common mutation of CF. Read the full article on the Cystic Fibrosis Foundation website
